Biopharma expert Ivan Kairatov joins us to discuss a groundbreaking advance in immunotherapy. While treatments like CAR-T cell therapy have shown incredible promise, they are not a solution for every patient, often because the necessary immune cells are rare or difficult to work with. Now,
A groundbreaking discovery has unveiled a class of small molecules that effectively teach the body to eliminate its own disease-causing components, a development that could rewrite the rules for treating some of the most stubborn medical conditions. An international team of scientists has
With over two decades of research in biopharma, Ivan Kairatov has witnessed the evolution of microbiome science from a niche interest into a central player in our understanding of health. As an expert in R&D and technological innovation, he has a unique perspective on the translational gap—the
The convergence of advanced computational intelligence with molecular biology has fundamentally altered the paradigm of vaccine development, shifting it from a process of slow, empirical discovery to one of rapid, data-driven design. The application of Artificial Intelligence (AI) in this field
The relentless search for an effective treatment for Alzheimer's disease has long been a monumental challenge for modern medicine, often characterized by a slow, costly, and high-failure process of drug discovery. A groundbreaking study now presents a powerful computational framework that promises
The dream of long-duration missions to the Moon and Mars carries with it a harsh physiological reality: the human body, evolved for Earth's gravity, deteriorates alarmingly in space. Prolonged exposure to microgravity triggers a cascade of deconditioning effects, including severe muscle atrophy,
